Related content

Outcome following surgical therapy for gastrointestinal stromal tumors

By Gupta Maneesh   Sheppard Brett   Corless Christopher   MacDonell Karen   Blanke Charles   Billingsley Kevin  

Journal of Gastrointestinal Surgery, Vol. 10, Iss. 8, 2006-08 ,pp. : 1099-1105

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors

By  

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems

By Zhong Jian-Hong   Ma Liang   Li Le-Qun   Ru Hai-Ming   Zhao Yin-Nong  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 6, 2011-06 ,pp. : 645-651

Informa Healthcare

Access to resources Recommend Favorite

State of the Art in the Treatment of Gastrointestinal Stromal Tumors

By  

Gastrointestinal Tumors, Vol. 1, Iss. 4, 2015-04 ,pp. : 221-236

Karger

Access to resources Recommend Favorite

A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients

By Sawaki Akira   Yamao Kenji   Nakamura Tsuneya   Suzuki Takashi   Okubo Kenji   Hara Kazuo   Kawai Hiroki   Yamamura Yoshitaka   Ito Seiji   Mochiduki Yoshinari   Ohno Ryuzo  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite